Contact Us    855-RIA-PLAN (855-742-7526)

MREO: Mereo BioPharma Group plc Stock

By | July 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 140.16
Enterprise Value ($M) n/a
Book Value ($M) 80.68
Book Value / Share 0.74
Price / Book n/a
NCAV ($M) 56.10
NCAV / Share 0.52
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.27
Return on Assets (ROA) -0.43
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 12.19
Current Ratio 12.19

Balance Sheet (mrq) ($M)
Current Assets 120.33
Assets 144.92
Liabilities 64.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
12-02 13G Rubric Capital Management LP 10.38
03-01 13G Point72 Asset Management, L.P. 6.40
02-19 13G Suvretta Capital Management, Llc 5.90
02-16 13G/A Vivo Capital IX, LLC 8.17 -70.71
02-16 13G/A Boxer Capital, LLC 9.10 -49.37
02-16 13G/A Citadel Advisors Llc 8.90
02-16 13G Baker Bros. Advisors Lp 11.40
02-12 13G Orbimed Advisors Llc 6.66

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-01-18 133,512 618,743 21.58
2022-01-13 107,920 308,583 34.97

(click for more detail)

(click for list of largest short owners)

Similar Companies
MOLN – Molecular Partners AG MOR – MorphoSys AG
MORF – Morphic Holding Inc MRKR – Marker Therapeutics Inc
MRNA – Moderna Inc


Financial data and stock pages provided by
Fintel.io





2018/07/06
> Back to All Posts